机构:[1]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangdong Prov Key Lab Malignant Tumor Epigenet &, 107W Yanjiang Rd, Guangzhou, Guangdong, Peoples R China中山大学附属第二医院[2]Hebei Univ, Affiliated Hosp, Dept Urol, Baoding 071000, Hebei, Peoples R China医疗泌尿外科河北大学附属医院[3]Guangzhou Med Univ, Affiliated Hosp 5, Dept Urol, Guangzhou, Guangdong, Peoples R China[4]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China中山大学附属第二医院
Purpose: To explore the establishment of a scoring system that can provide a reference for clinical decision mak-ing regarding the endoscopic treatment of 1-2 cm lower pole stones (LPS).Materials and Methods: The data of patients with renal calculi who were treated with percutaneous nephrolithot-omy (PCNL) or retrograde intrarenal surgery (RIRS) in three hospitals from January 2013 to December 2017 were analyzed retrospectively. Multivariable logistic analysis was performed to determine the statistically significant indicators and regression coefficients, which were used to construct the scoring system. The stone-free rate (SFR) and postoperative complication rates of PCNL and RIRS within the two fractional segments of the scoring system were compared to select the optimal procedures.Results: A total of 137 patients in the PCNL group and 152 patients in the RIRS group were included in this study. Five factors were found to be most predictive of endoscopic treatment choice: stone number, stone diameter, infun-dibulopelvic angle (IPA), infundibular length (IL), and infundibular width (IW), yielding a total score ranging from 0-5. In the 0-2 segments, the RIRS group had better outcomes than the PCNL group in terms of the postoperative complication rates (6.8% versus 18.0%, P = .026). In segments 3-5, the SFR of the PCNL group was significantly higher than that of the RIRS group (88.5% versus 70.6%, P = .017).Conclusion: Our scoring system was based on the patient's preoperative imaging examination to measure the stone number, stone diameter, IPA, IL and IW. RIRS was recommended at 0-2 segments, and PCNL was recom-mended at 3-5 segments. This new scoring system is expected to provide guidance for urologists to make endo-scopic treatment decisions for 1-2 cm LPS.
基金:
National Natural of Science Foundation of China [8207841]; Science and Technology Program of Guangzhou, China [201803010029]; Sun Yat-Sen Clinical Research Cultivating Program from Sun Yat-sen Memorial Hospital of Sun Yat-sen University [SYS-C-201802]
第一作者机构:[1]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangdong Prov Key Lab Malignant Tumor Epigenet &, 107W Yanjiang Rd, Guangzhou, Guangdong, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangdong Prov Key Lab Malignant Tumor Epigenet &, 107W Yanjiang Rd, Guangzhou, Guangdong, Peoples R China[3]Guangzhou Med Univ, Affiliated Hosp 5, Dept Urol, Guangzhou, Guangdong, Peoples R China[4]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China[*1]Department of Urology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangdong, China.[*2]Department of Urology, Fifth Affiliated Hospital of Guangzhou Medical University, Guangdong, China
推荐引用方式(GB/T 7714):
Huang Yuleng,Li Kaiwen,Yang Wenzeng,et al.A Scoring System for Optimal Selection of Endoscopic Treatment for 1-2cm Lower Pole Renal Calculi[J].UROLOGY JOURNAL.2022,19(5):356-362.doi:10.22037/uj.v19i.7195.
APA:
Huang, Yuleng,Li, Kaiwen,Yang, Wenzeng,Li, Zhuohang,Liu, Cheng...&Xu, Kewei.(2022).A Scoring System for Optimal Selection of Endoscopic Treatment for 1-2cm Lower Pole Renal Calculi.UROLOGY JOURNAL,19,(5)
MLA:
Huang, Yuleng,et al."A Scoring System for Optimal Selection of Endoscopic Treatment for 1-2cm Lower Pole Renal Calculi".UROLOGY JOURNAL 19..5(2022):356-362